The
present study demonstrates the use of highly stable single-molecule
enzyme nanocapsules (SMENs) instead of traditional native enzyme as
biorecognition element in enzyme-based biosensors. The main purpose
of this study is to resolve the major obstacle and challenge in the
biosensor field, i.e., the poor stability of enzyme-based biosensors,
including thermal stability, organic solvent tolerance, long-term
operational stability, etc. Highly active and robust SMENs of glucose
oxidase (GOx, as a model enzyme) were synthesized (nGOx) using an
in situ polymerization strategy in an aqueous environment. The particle-size
distribution, transmission electron microscopic (TEM) images, and
UV–vis spectral characterization revealed the formation of
a thin polymer layer around each enzyme molecule. The polymer shell
effectively stabilized the GOx enzyme core while enabling rapid substrate
transportation, resulting in a new class of biocatalytic nanocapsules.
Multiple covalent attachments between a thin polymer layer and an
enzyme molecule strengthened the encapsulated GOx molecule. Encapsulation
created a favorable microenvironment to avoid any structural dissociation
at high temperature and helped to retain essential water during the
organic solvent operation. The present work reports a study implementing
nGOx SMENs as highly stable nano(bio)sensors for point-of-care diagnostic
applications. Prepared nGOx SMENs manifested significantly improved
thermal stability (even at 65 °C) and organic solvent tolerance
without any compromise in biocatalytic activity. For example, the
native GOx-based biosensor lost its catalytic activity for glucose
after 4 h of incubation at high temperature (65 °C), while the
nGOx/N-CNTs-Chi/GCE nano(bio)sensor maintained ∼56% of its
original catalytic activity for glucose oxidation. The proposed SMENs-based
nano(bio)sensors with robust stability in variable working environment
could promote the development and applications of biosensors in point-of
care diagnostics, biomedical detection, wearable devices, implantable
equipment, and biofuel cells.